Savara (SVRA) Accumulated Expenses (2010 - 2026)

Savara's (SVRA) quarterly Accumulated Expenses came in at $11.0 million in Q1 2026, up 979.47% year-on-year from $1.0 million in Q1 2025, and down 24.56% on a QoQ basis from $14.6 million in Q4 2025.

Savara (SVRA) Accumulated Expenses (2010 - 2026) Analysis & Trends

Savara (SVRA) has 17 years of Accumulated Expenses data on file, last reported at $11.0 million in Q1 2026.

  • On a quarterly basis, Accumulated Expenses rose 979.47% year-over-year to $11.0 million in Q1 2026; TTM through Mar 2026 was $11.0 million, a 979.47% increase from a year earlier, with the FY2025 full-year figure at $14.6 million, up 191.79% from the prior year.
  • Accumulated Expenses for Q1 2026 stood at $11.0 million, down from $14.6 million in the prior quarter.
  • Over the last five years, Accumulated Expenses for SVRA reached as high as $14.6 million in Q4 2025 and fell as low as $590000.0 in Q1 2022.
  • Historically, Accumulated Expenses has averaged $4.3 million across 5 years, with a median of $2.9 million in 2022.
  • Across the five-year window, Accumulated Expenses tumbled 71.41% in 2025 and surged 979.47% in 2026, its largest moves.
  • Year by year, Accumulated Expenses stood at $2.4 million in 2022, then surged by 199.92% to $7.1 million in 2023, then retreated by 29.27% to $5.0 million in 2024, then surged by 191.79% to $14.6 million in 2025, then slipped by 24.56% to $11.0 million in 2026.
  • Per Business Quant data, the three most recent Accumulated Expenses figures were $11.0 million in Q1 2026, $14.6 million in Q4 2025, and $3.9 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Savara 1.24 Bn 1.24 Bn -

Historic Data

Download Data
DateValue
Mar 31, 2026 11.04 Mn
Dec 31, 2025 14.64 Mn
Sep 30, 2025 3.92 Mn
Jun 30, 2025 2.26 Mn
Mar 31, 2025 1.02 Mn
Dec 31, 2024 5.02 Mn
Sep 30, 2024 2.84 Mn
Jun 30, 2024 7.90 Mn
Mar 31, 2024 757,000.00
Dec 31, 2023 7.09 Mn
Sep 30, 2023 2.18 Mn
Jun 30, 2023 3.38 Mn
Mar 31, 2023 603,000.00
Dec 31, 2022 2.37 Mn
Sep 30, 2022 4.27 Mn
Jun 30, 2022 2.90 Mn
Mar 31, 2022 590,000.00
Dec 31, 2021 4.88 Mn
Sep 30, 2021 5.22 Mn
Jun 30, 2021 1.53 Mn